Stock Analysis

Interim CEO & Director of Bactiguard Holding Picks Up 3.1% More Stock

OM:BACTI B
Source: Shutterstock

Bactiguard Holding AB (publ) (STO:BACTI B) shareholders (or potential shareholders) will be happy to see that the Interim CEO & Director, Thomas von Koch, recently bought a whopping kr9.1m worth of stock, at a price of kr59.61. While that only increased their holding size by 3.1%, it is still a big swing by our standards.

Check out our latest analysis for Bactiguard Holding

The Last 12 Months Of Insider Transactions At Bactiguard Holding

In fact, the recent purchase by Interim CEO & Director Thomas von Koch was not their only acquisition of Bactiguard Holding shares this year. They previously made an even bigger purchase of kr24m worth of shares at a price of kr63.39 per share. That means that even when the share price was higher than kr62.00 (the recent price), an insider wanted to purchase shares. It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. Thomas von Koch was the only individual insider to buy shares in the last twelve months.

Thomas von Koch bought a total of 537.15k shares over the year at an average price of kr62.32. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
OM:BACTI B Insider Trading Volume November 10th 2023

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insider Ownership Of Bactiguard Holding

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. It appears that Bactiguard Holding insiders own 10% of the company, worth about kr226m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

What Might The Insider Transactions At Bactiguard Holding Tell Us?

It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Bactiguard Holding. That's what I like to see! While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. At Simply Wall St, we found 1 warning sign for Bactiguard Holding that deserve your attention before buying any shares.

Of course Bactiguard Holding may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Valuation is complex, but we're here to simplify it.

Discover if Bactiguard Holding might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About OM:BACTI B

Bactiguard Holding

A medical device company, provides infection prevention solutions in orthopedics, urology, intravascular/critical care, dental, and wound care therapeutic areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally.

Reasonable growth potential and fair value.